Dr. Hisham S. ElBanawy

MBBCh, M.Sc., M.D. — Chemical & Clinical Pathology
GCC Medical Director – Al Borg Diagnostics, ME.  |  General Manager – Al Borg Labs, Qatar.  |  A. Professor at M.R.I., Alexandria University, Egypt.  |  Senior Consultant of Laboratory Medicine.  |  Expert at MOPH, Qatar.
Doha, Qatar
LinkedIn ↗ Google Scholar ↗

Profile

About

Senior laboratory medicine executive and consultant pathologist with over 25 years of experience spanning clinical practice, academic medicine, and multi-site laboratory leadership across the GCC and Egypt. Currently GCC Medical Director at Al Borg Diagnostics, overseeing medical and scientific strategy, clinical governance, and CAP/JCI/ISO/MOH accreditation compliance across the region. Track record of leading laboratories to repeated CAP and JCI accreditation and re-accreditation, building quality management systems, and driving operational and financial performance across hospital and reference laboratory networks.

GCC Medical Director — Al Borg Diagnostics, Middle East
General Manager & Medical Director — Al Borg Medical Laboratories, Qatar
Assistant Professor — Medical Research Institute, Alexandria University, Egypt
Member, Lab Doctors Evaluation Committee — Ministry of Public Health, Qatar

Credentials

Accreditation Credentials

College of American Pathologists

College of American Pathologists (CAP)

Laboratory Director — CAP #: 9053433
Al Borg Med Lab Co. – Qatar (Al Waab)
Accredited through May 05, 2027
Joint Commission International

Joint Commission International (JCI)

IHCO ID: 60004148
Al Borg Medical Laboratories Network — Al Waab & Duhail Labs
Accredited through Oct 29, 2028
CAP-accredited services: All Common, Anatomic Pathology Processing, Bacteriology, Body Fluid Analysis, Chemistry, Coagulation, Cytology Processing & Screening, Director Assessment, Gynecologic & Non-Gynecologic Cytopathology, Hematology, Immunology, Laboratory General, Mycology, Parasitology, Special Chemistry, Surgical Pathology, and Urinalysis.

Career

Professional Experience

GCC Medical Director
May 2026 – Present
Al Borg Diagnostics, Middle East
Medical & Scientific Leadership
  • Lead and guide medical and scientific strategy across the GCC
  • Ensure adherence to international best practices and accreditation requirements (CAP, JCI, ISO, MOH)
  • Drive clinical excellence, ensuring high standards of accuracy, reliability, and patient safety
  • Promote evidence-based practices and continuous improvement in diagnostic outcomes
Clinical Governance & Quality
  • Establish and monitor quality control programs to ensure precision and reliability
  • Conduct audits, risk assessments, and compliance reviews
  • Ensure full readiness for accreditation and regulatory compliance
Laboratory Operations & Efficiency
  • Standardize and enforce laboratory workflows, SOPs, and unified processes across all labs
  • Ensure Turnaround Time (TAT) targets are consistently achieved
  • Optimize analyzer utilization and minimize operational idle time
  • Improve manpower productivity and maintain cost efficiency within approved budgets
Network Optimization, Strategic Advisory & Capability Building
  • Network design, footprint optimization, and test consolidation/centralization
  • Act as medical advisor to senior leadership (CEO, Country GMs); primary liaison with regulators and ministries of health
  • Develop and implement continuous medical education (CME) programs for laboratory staff
General Manager & Medical Director
Nov 2007 – Present
Al Borg Medical Laboratories Co. Ltd., Qatar
  • Ensure competent daily operation of all laboratory processes, delivering accurate and reliable results within defined turnaround times
  • Oversee financial performance including revenue management, cost control, and sustainable profitability
  • Direct and manage multiple laboratories across hospitals and medical centers through management and expansion projects
  • Lead the Quality Assurance Program, including CAP and JCI accreditation readiness, standards compliance, and QC/proficiency testing oversight
  • Perform internal audits and inspections to ensure continuous readiness for accreditation surveys
  • Implement and maintain compliance with CAP and JCI standards; approve alternative assessment (APA) methodologies when required
  • Maintain a safe laboratory environment and evaluate new procedures, services, technologies, and equipment prior to implementation
  • Maintain effective liaison and regulatory compliance with governmental and non-governmental authorities
Member, Ministry of Public Health Expert Committee
Nov 2018 – Present
Ministry of Public Health, Qatar
Member, Lab Doctors Evaluation Committee
Oct 2014 – Present
Ministry of Public Health, Qatar
Assistant Professor
Jan 2012 – Present
Medical Research Institute, Alexandria University, Egypt
General Manager of Laboratories
Sep 2003 – Oct 2007
Pharos Medical Laboratories, Alexandria, Egypt
Laboratory Director
Jun 2002 – Aug 2003
Al Saad Hospital, Alexandria, Egypt
Laboratory Specialist
Sep 1999 – Jun 2002
Pharos Medical Laboratories, Alexandria, Egypt

Academic Background

Education

Doctorate (M.D.) of Chemical Pathology
Medical Research Institute, Alexandria University
Dec 2005
Master (M.Sc.) of Chemical Pathology
Medical Research Institute, Alexandria University
Mar 2002
Bachelor of Medicine and Surgery (MBBCh)
Faculty of Medicine, Alexandria University
Oct 1997

Licensure & Academic Progression

Laboratory Medicine / Clinical Pathology — License No. 116805
General Syndicate of Egyptian Doctors, Egypt
Senior Consultant, Dec 2010 – Present | Consultant, Dec 2008 – Dec 2010 | Specialist, Mar 2002 – Dec 2008
Laboratory Medicine / Anatomical & Clinical Pathology — License No. P3403
Ministry of Public Health, Qatar
Senior Consultant, Dec 2020 – Present | Consultant, Dec 2015 – Dec 2020 | Specialist, Feb 2008 – Dec 2015
Laboratory Medicine / Clinical Pathology — License No. 5876
Ministry of Health, Egypt
Senior Consultant, Dec 2010 – Present | Consultant, Dec 2008 – Dec 2010 | Specialist, Mar 2002 – Dec 2008
Academic Track — Chemical Pathology Department, M.R.I., Alexandria University
Laboratory Doctor, Apr 1999 – Dec 1999 → Resident, Dec 1999 – Dec 2002 → Assistant Lecturer, Jan 2003 – Dec 2005
Lecturer, Jan 2006 – Jan 2012 → Assistant Professor, Jan 2012 – Present

Skills

Core Competencies

Leadership & Governance

Executive Leadership, Corporate Governance, Change Management, Stakeholder Management, Decision Making, Business Development, Strategic Problem Solving, KPI Governance, High Emotional Intelligence

Business & Finance

Commercial Strategy, P&L Management, Budgeting, Financial Control, Business Planning, Value Creation, Sustainable & Profitable Revenue Growth, Cost Control & Workforce Productivity, KPI Monitoring

Operations & Quality

Operational Excellence, Risk Management, CAP & JCI Accreditation Compliance, Quality Management Systems

Digital & Strategy

Strategic Thinking, Digital Transformation, Data Analytics, Executive Reporting, IT & Systems Integration

Professional Training & Certifications

Accreditation Canada Inspector Course High Impact Leadership in Health Care Analytical and Clinical Validation Automating Clinical Testing with LIMS Calibration Verification Ethics and Professionalism in Healthcare Designing Risk Managed QC Strategies Quality Management Advanced Quality Control Basics of Lean and Six Sigma for the Laboratory Immediate Life Support (ILS) Lab Automation Infection Prevention & Control Creating Laboratory Value Packaging and Shipping of Infectious Materials Laboratory Safety & Chemical Hygiene The Laboratorian as a Clinical Consultant Pros and Cons of Selling the Laboratory

Research

Selected Publications

  1. The association between Malnutrition, Inflammation and Atherosclerosis in Hemodialysis Patients. Hemodialysis International, 2007.
  2. The role of BMP-7 and TGF-beta1 in diabetic nephropathy. Journal of Medical Research Institute, 2007.
  3. Role of plasma refill rate, its determinants and other variables in pathogenesis of intradialytic hypotension. Journal of Medical Research Institute, 2008.
  4. The diagnostic value of Pregnancy Associated Plasma Protein–A (PAPP-A) in male patients with acute coronary syndrome. Journal of Medical Research Institute, 2008.
  5. Decreased serum 25-hydroxy Vitamin D as a cardiovascular risk factor in type-2 diabetic patients. The Journal of the Egyptian Society of Endocrinology, Metabolism & Diabetes, 2009.
  6. The role of adiponectin and C-peptide in the development of diabetic nephropathy in adult females. The Journal of the Egyptian Society of Endocrinology, Metabolism & Diabetes, 2009.
  7. Oxidative stress and urotensin-II may play a role in preeclampsia development rather than eNOS glu-asp 298 polymorphism. The Arab Journal of Laboratory Medicine, 2010.
  8. Pre-, intra- and post-operative plasma levels of soluble P-selectin in diabetics under thoracic paravertebral block versus general anesthesia. The Egyptian Journal of Immunology, 2010.
  9. The relation between serum leptin, hypertension, gestational diabetes and weight gain in pregnant females. The Journal of the Egyptian Society of Endocrinology, Metabolism & Diabetes, 2010.
  10. Study of Plasma Cholecystokinin and Glucagon-like Peptide-1 as short satiety signals in obese subjects. The Journal of the Egyptian Society of Endocrinology, Metabolism & Diabetes, 2010.
  11. Serum matrix metalloproteinase-9 and its tissue inhibitor-1 in hemodialysis patients as a predictor of cardiovascular complications. The Arab Journal of Laboratory Medicine, 2011.
  12. Brain natriuretic peptide (BNP), bioimpedance and left ventricular function and their relation to volume overload in hemodialysis patients. The Arab Journal of Laboratory Medicine, 2011.
  13. Silent myocardial ischemia in diabetic patients after general anesthesia with 24h intravenous opioids or with epidural anesthesia. Egyptian Journal of Anesthesia, 2011.
  14. Angiotensin Converting Enzyme Gene I/D polymorphism correlates with complications in HCV infected Egyptian patients. Global Journal of Medical Research, 2011.
  15. High level of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Acute Leukemia – prognostic value. The Egyptian Journal of Hematology, 2011.
  16. Primary and secondary glomerulonephritis I. Nephrology Dialysis Transplantation, 2012.
  17. Renal tubular function and its relationship to adiponectin and oxidative stress in obese subjects with and without evidence of nephropathy. Nephrology Dialysis Transplantation, 2012.
  18. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus. Journal of Nephrology, 2012.
  19. Glomerular and tubular dysfunctions and their relationship to adiponectin and oxidative stress in obese subjects. Hong Kong Journal of Nephrology, 2012.
  20. Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients. Alexandria Journal of Medicine, 2015.
  21. Pulmonary Lophomoniasis: An overlooked cause of non-resolving pneumonia. Batna Journal of Medical Sciences, 2025.
  22. Diagnostic Challenges in HSV-2 Serology: Comparative Performance of ELISA and Western Blot Assays and the Need for Confirmatory Testing. Research Square (reprint), 2025.
  23. Toxoplasma gondii IgG Seroprevalence in Qatar and the Impact of Assay Variability on Epidemiological Estimates. Acta Tropica Journal, 2026.
  24. Consistent performance of cytomegalovirus IgG assays across platforms contrasts with marked IgM variability, supporting IgG avidity–based infection classification in a high-prevalence population. Qatar University Digital Hub, 2026.

Community

Professional Affiliations & Memberships

American Association for Clinical Chemistry (AACC) — Middle East Conference Chairman
MEDLAB — Middle East, UAE
Arab Health (World Health Expo), UAE
Association for Diagnostics & Laboratory Medicine (ADLM) — AACC Conferences, USA
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) — Germany, Italy
Languages: English (Excellent), Arabic (Mother tongue)

Get in Touch

Contact

Email
hisham373@hotmail.com  –  h.elbanawy@alborgdx.com
Location
Doha, Qatar
LinkedIn
linkedin.com/in/hisham-elbanawy
Google Scholar
View publications